Internships at Definium Therapeutics
Definium Therapeutics is a late-stage clinical biopharmaceutical company developing psychedelic medicines for brain health disorders. Its lead candidate, DT120, is a lysergide tartrate formulation in Phase 3 studies for generalized anxiety disorder and major depressive disorder.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 12
No current roles
Clear a filter to see every role.
Get new Definium Therapeutics internships by email
Free account. Get new Definium Therapeutics internships by email or push the minute they post.
